Currently, Namodenoson is being evaluated in a pivotal Phase 3 multinational registrational trial for the treatment of ...

B.Riley Financial analyst Mayank Mamtani reiterated a Buy rating on Agenus (AGEN – Research Report) today and set a price target of $11.00.Stay ...

Stifel Nicolaus analyst Benjamin Burnett has maintained their bullish stance on PGEN stock, giving a Buy rating today.Don't Miss Our New ...

ASCO commits to collaborating with the ICC site over a period ... These solutions may include implementing new technologies, improving care coordination processes, or enhancing the accessibility of ...

Abstracts will be published on the ASCO Gastrointestinal Cancers Symposium ... to anticipated developments in Oncolytics' business and technologies. In any forward-looking statement in which ...

ASCO GI is one of the most influential global conferences ... Although mRNA has advantages such as rapid development speed and high efficacy compared to existing vaccine technologies, it requires ...

Advancing gastrointestinal cancer pipeline underscores potential for additional registration-enabling studies SAN DIEGO and CALGARY, AB, Dec. /PRNewswire/ -- Oncolytics B ...

Treatment Pattern and Outcome of Locally Advanced Rectal Cancer in Resource-Constrained Countries: Experience at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia In the era of precision ...

Dr is providing care to patients at the FCS Lake Mary Cancer Center , Deland and Orange City locations. John Bollinger, MD ...

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and ...